Cargando…
PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm
BACKGROUND: Primary tracheobronchial neoplasm is rare yet poses a serious threat to life. Due to its low incidence, the immune microenvironment of such tumors remained unclear. This study aimed to clarify the expression of programmed death-ligand 1 (PD-L1) and infiltration of immune cells in primary...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743529/ https://www.ncbi.nlm.nih.gov/pubmed/35070765 http://dx.doi.org/10.21037/tlcr-21-958 |
_version_ | 1784629921998438400 |
---|---|
author | Zheng, Kai-Fu Liu, Yu-Jian Ma, Nan Xiong, Yan-Lu Tang, Xi-Yang Zhang, Qian Luo, Zhong-Lin Tian, Huan-Huan Hofman, Paul Ichiki, Yoshinobu Metro, Giulio Tachihara, Motoko Gong, Li Li, Xiao-Fei Zhao, Jin-Bo |
author_facet | Zheng, Kai-Fu Liu, Yu-Jian Ma, Nan Xiong, Yan-Lu Tang, Xi-Yang Zhang, Qian Luo, Zhong-Lin Tian, Huan-Huan Hofman, Paul Ichiki, Yoshinobu Metro, Giulio Tachihara, Motoko Gong, Li Li, Xiao-Fei Zhao, Jin-Bo |
author_sort | Zheng, Kai-Fu |
collection | PubMed |
description | BACKGROUND: Primary tracheobronchial neoplasm is rare yet poses a serious threat to life. Due to its low incidence, the immune microenvironment of such tumors remained unclear. This study aimed to clarify the expression of programmed death-ligand 1 (PD-L1) and infiltration of immune cells in primary tracheobronchial neoplasm, which might be useful for guiding treatment and evaluating clinical outcome. METHODS: We assessed retrospectively the expression of PD-L1 and infiltration in cells expressing CD8, CD16, CD68, CD163 and FOXP3 in 21 patients with primary tracheobronchial neoplasm who underwent surgery in Tangdu Hospital from January 2016 to July 2021. The expression of PD-L1 was assessed based on the tumor proportion score system. The density of immune cells was analyzed by automatic image analysis software. RESULTS: In this study, all of 16 participants with adenoid cystic carcinoma (ACC) had no expression of PD-L1, whereas 4/5 (80%) of those with squamous cell carcinomas (SCC) were positive for PD-L1 expression. Compared with ACC, the density of FOXP3(+) cells in both the intratumoral region and peritumoral region was higher in SCC (P<0.01). The density of FOXP3(+) cells was significantly higher than that of CD8(+), CD16(+), and CD163(+) cells in SCC in the intratumoral region (P<0.01). In contrast, the density of FOXP3(+) cells was significantly lower than that of CD8(+), CD16(+), and CD68(+) cells in ACC in both the intratumoral region and peritumoral regions. The density of CD68(+) cells was significantly higher than that of CD8(+) cells (P<0.05) and CD163(+) cells (P<0.01) in ACC in the intratumoral region. Furthermore, the tumors of patients with metastasis more commonly of immune-excluded status, in which the CD8(+) cells accumulated in peritumoral region. CONCLUSIONS: This study demonstrated that the expression of PD-L1 in primary tracheobronchial neoplasm was mainly concentrated in patients with SCC. In the immune microenvironment of SCC, FOXP3(+) cells were the dominant immune cells, while in the immune microenvironment of ACC, CD68(+) cells were the main immune cells. Therefore, the immune microenvironment was significantly different in primary tracheobronchial neoplasm according to histology. |
format | Online Article Text |
id | pubmed-8743529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87435292022-01-21 PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm Zheng, Kai-Fu Liu, Yu-Jian Ma, Nan Xiong, Yan-Lu Tang, Xi-Yang Zhang, Qian Luo, Zhong-Lin Tian, Huan-Huan Hofman, Paul Ichiki, Yoshinobu Metro, Giulio Tachihara, Motoko Gong, Li Li, Xiao-Fei Zhao, Jin-Bo Transl Lung Cancer Res Original Article BACKGROUND: Primary tracheobronchial neoplasm is rare yet poses a serious threat to life. Due to its low incidence, the immune microenvironment of such tumors remained unclear. This study aimed to clarify the expression of programmed death-ligand 1 (PD-L1) and infiltration of immune cells in primary tracheobronchial neoplasm, which might be useful for guiding treatment and evaluating clinical outcome. METHODS: We assessed retrospectively the expression of PD-L1 and infiltration in cells expressing CD8, CD16, CD68, CD163 and FOXP3 in 21 patients with primary tracheobronchial neoplasm who underwent surgery in Tangdu Hospital from January 2016 to July 2021. The expression of PD-L1 was assessed based on the tumor proportion score system. The density of immune cells was analyzed by automatic image analysis software. RESULTS: In this study, all of 16 participants with adenoid cystic carcinoma (ACC) had no expression of PD-L1, whereas 4/5 (80%) of those with squamous cell carcinomas (SCC) were positive for PD-L1 expression. Compared with ACC, the density of FOXP3(+) cells in both the intratumoral region and peritumoral region was higher in SCC (P<0.01). The density of FOXP3(+) cells was significantly higher than that of CD8(+), CD16(+), and CD163(+) cells in SCC in the intratumoral region (P<0.01). In contrast, the density of FOXP3(+) cells was significantly lower than that of CD8(+), CD16(+), and CD68(+) cells in ACC in both the intratumoral region and peritumoral regions. The density of CD68(+) cells was significantly higher than that of CD8(+) cells (P<0.05) and CD163(+) cells (P<0.01) in ACC in the intratumoral region. Furthermore, the tumors of patients with metastasis more commonly of immune-excluded status, in which the CD8(+) cells accumulated in peritumoral region. CONCLUSIONS: This study demonstrated that the expression of PD-L1 in primary tracheobronchial neoplasm was mainly concentrated in patients with SCC. In the immune microenvironment of SCC, FOXP3(+) cells were the dominant immune cells, while in the immune microenvironment of ACC, CD68(+) cells were the main immune cells. Therefore, the immune microenvironment was significantly different in primary tracheobronchial neoplasm according to histology. AME Publishing Company 2021-12 /pmc/articles/PMC8743529/ /pubmed/35070765 http://dx.doi.org/10.21037/tlcr-21-958 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Zheng, Kai-Fu Liu, Yu-Jian Ma, Nan Xiong, Yan-Lu Tang, Xi-Yang Zhang, Qian Luo, Zhong-Lin Tian, Huan-Huan Hofman, Paul Ichiki, Yoshinobu Metro, Giulio Tachihara, Motoko Gong, Li Li, Xiao-Fei Zhao, Jin-Bo PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title | PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title_full | PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title_fullStr | PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title_full_unstemmed | PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title_short | PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
title_sort | pd-l1 expression and immune cells infiltration in primary tracheobronchial neoplasm |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743529/ https://www.ncbi.nlm.nih.gov/pubmed/35070765 http://dx.doi.org/10.21037/tlcr-21-958 |
work_keys_str_mv | AT zhengkaifu pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT liuyujian pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT manan pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT xiongyanlu pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT tangxiyang pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT zhangqian pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT luozhonglin pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT tianhuanhuan pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT hofmanpaul pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT ichikiyoshinobu pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT metrogiulio pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT tachiharamotoko pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT gongli pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT lixiaofei pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm AT zhaojinbo pdl1expressionandimmunecellsinfiltrationinprimarytracheobronchialneoplasm |